Aclaris Therapeutics Financial Overview
Aclaris Therapeutics's market cap is currently $314.20M. The company's EPS TTM is $-0.12; its P/E ratio is -2.10; Aclaris Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
